View
240
Download
0
Embed Size (px)
Citation preview
8/9/2019 Gmp Partii
1/76
1
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality
Prequalification Programme: Priority ssential !edicines
8/9/2019 Gmp Partii
2/76
2
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality
Prequalification Programme: Priority ssential !edicines
Good Manufacturing Practices Part II
3 Specific GMP topics:Premises, Documentation and Validation
Anton Norder, MScTechnical Officer
WHO EMRO 1stWorkshop on the WHO Prequalification
Programme: Priority Essential Medicines
!airo Egypt " and # $une %&
2
%& '(enue 'ppia
!H)1%11 *ene(a %#
+,it-erland
E)mail:nordera who.int
8/9/2019 Gmp Partii
3/76
3
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality
Prequalification Programme: Priority ssential !edicines
Guidelines and references
.ooklet:
/uality 'ssurance of pharmaceuticals0 ' compendium of guidelines
and related materials0 olume % second updated edition0 *ood
manufacturing practices and inspection0 World Health Organi-ation
*ene(a %& *ood Manufacturing Practices for pharmaceutical products: main
principles0 WHO Technical Report +eries 2o0 3&4 %&&5 'nne6 70
*ood Manufacturing Practices: starting materials0 WHO Technical Report
+eries 2o0 4%5 133%0
8!H /#': *ood Manufacturing Practice *uide for 'cti(e
Pharmaceutical 8ngredients International Conference onHarmonizationhttp:99,,,0ich0org9cache9compo9%#")%7)10html
http://www.ich.org/cache/compo/276-254-1.htmlhttp://www.ich.org/cache/compo/276-254-1.html8/9/2019 Gmp Partii
4/76
4
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable Quality
Prequalification Programme: Priority ssential !edicines
WHO Guidelines and references cont!d"
WHO *ood Manufacturing Practices: ,ater for pharmaceutical use0WHO Technical Report +eries 2o0 3%3 %&& 'nne6 5http:99,hqli;doc0,ho0int9trs9WHO
8/9/2019 Gmp Partii
5/76
8/9/2019 Gmp Partii
6/766
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
Ho#e$er t%ere!s more GMP!s:
P8!9+ *MP @Pharmaceutical 8nspection !o)operation +chemeA:
,,,0picscheme0orgB adopted ;y many countries e0g0
European Cnion or partially @!anada 'ustraliaA
2ational *MPDs in many countries @e0g0 C+' @,,,0fda0go(A
!hina 8ndia .ra-il 'rgentina etc0A
8nternational !onference on Harmoni-ation @8!HA: ,,,0ich0org
'lso refer to 8+O e0g in cases of filter types in H'!s clean
room design risk management etc0
http://www.picscheme.org/http://www.fda.gov/http://www.ich.org/http://www.ich.org/http://www.fda.gov/http://www.picscheme.org/8/9/2019 Gmp Partii
7/767
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
O$er$ie# of specific GMP topics to &e
co$ered in t%is presentation:
Part 1:
Premises in relation to ;uildings design equipment etc0
Part %:
Documentation
Part 5:
ua!i"ication and #a!idation
8/9/2019 Gmp Partii
8/76$
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
Q C Ofces
Gowning
Canteen
Incoming
goods
Corridor
CorridorShipping
Corridor
Packaging
Weighing Processing
Filling
Raw
Materials
&
Packaging
Storage
Washing Machine
Shop
Finished
Prodcts
Storage
Corridor
!tilities and Ser"ices
Waste #reatment
Part ': Premises
Arri#a! o" %oods &isitors entrance 'or(ers entrance Shi)ment o" %oods
Materia! *!ow
Peo)!e *!ow
+one -!ean +one Pac(a%in%
+one -ontro!!ed
8/9/2019 Gmp Partii
9/76
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
12.11 / 12.36
Premises: specific areas
Note that s)eci"ic re0uirements are %i#en "or s)eci"ic areas
'ncillary areas @go,ning rooms toilets refreshment rooms
maintenance areas animal housing etcA
+torage areas
Weighing areas
Production areas
/uality control areas
8/9/2019 Gmp Partii
10/76
1
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
12.11 / 12.14
Premises: ancillar( areas
Rest and refreshment rooms separate from manufacturing and
quality control areas
!hanging ,ashing and toilet areas accessi;le and appropriate
num;ers
Maintenance ,orkshops separated from production ) if not possi;le
tools in reser(ed areas
'nimal houses ,ell isolated separate air handling and entrance
8/9/2019 Gmp Partii
11/76
11
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
Premises: ancillar( areas
T O 8 = E T +
' 8R
= O ! F
! ' 2 T E E 2
G ' ! T O R ! H ' 2 * E
R O O M
8/9/2019 Gmp Partii
12/76
12
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
Premises: ancillar( areas
8/9/2019 Gmp Partii
13/76
13
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
Premises: )eceipt and storage of goods
Se)arate recei#in% and
dis)atch as Materials and
products protectedfrom weather
Area to c!ean incomin%
materia!s )ro#ided
8/9/2019 Gmp Partii
14/76
14
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
Premises: )eceipt and storage of goods
-!eanin% o" incomin%
containers
Cleaning with a cloth, or
duster
Cleaning by using a vacuum
cleaner
Use of air curtains and air
tunnels
8/9/2019 Gmp Partii
15/76
15
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
12.15, 12.16
Premises: )eceipt and storage of goods
+torage areas of sufficient capacity
Orderly storage of categories of materials and products
+eparate and segregated areas: starting materials packaging
materials intermediates ;ulk finished products quarantined
released reIected returned and recalled products and materials
8/9/2019 Gmp Partii
16/76
16
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
Premises: )eceipt and storage of goods
8/9/2019 Gmp Partii
17/76
17
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
Premises: )eceipt and storage of goods
8/9/2019 Gmp Partii
18/76
1$
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
12.16, 12.17
Premises: )eceipt and storage of goods
A))ro)riate tem)erature and re!ati#e humidit conditions
within de"ined !imits Provided, controlled, monitored and recorded
ood stora%e conditions clean dry and appropriate lights
8/9/2019 Gmp Partii
19/76
1
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
12.1$ / 12.2, 12.22
Premises: )eceipt and storage of goods
uarantine area clearly marked and access restricted
Se)arate sam)!in% area is the norm: no risk for contamination or
cross)contamination
Se%re%ated areas for reIected recalled and returned materials and
products
Sa"e and secure areas for highly acti(e radioacti(e materials
narcotics and other materials @risk of a;use fire e6plosionA
8/9/2019 Gmp Partii
20/76
2
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
Premises: )eceipt and storage of goods
8/9/2019 Gmp Partii
21/76
21
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
12.21
Premises: )eceipt and storage of goods
Printed )ac(a%in% materia!s
Critical to ensure correct labelling of products
Special attention to sampling of printed pacaging materials
Special attention to safe and secure storage
!nsure compliance with specifications, prevent mi"#ups
8/9/2019 Gmp Partii
22/76
22
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
12.23
Premises: #eig%ing
Weighing operations in separated areas
'ppropriate design @see also *MP on H'!A
Pro(ision for dust control +mooth imper(ious dura;le easy)to)clean finishes
!leaning procedures and records
Jocumentation e0g0 +OPs logs and records
8/9/2019 Gmp Partii
23/76
23
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
Premises: #eig%ing
8/9/2019 Gmp Partii
24/76
24
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
)e*uirements on premises:
Desi%n
Walls floors ceilings ledges drains air supply dust e6traction
Pre#ention o" ui!du) o" dirt and dust to a#oid unnecessarris(s o" contamination
!leaning programme appropriate cleaning cleaning records ""ecti#e c!eanin% and disin"ection
!hoice of materials and chemicals (alidation
Drains / )re#ent ac("!ow
Protection "rom insects, irds, #ermin and weather from receipt of ra, materials to dispatch of released product
12.2, 12.3, 12.7, 12.9, 12.29
8/9/2019 Gmp Partii
25/76
25
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
Design of premises:
'a!!s, "!oors, cei!in%s /
smooth and eas to
c!ean
No !ed%es or areas
where dust canaccumu!ate
Pre#ention o" ui!du)
o" dirt and dust to
a#oid unnecessar
ris(s o" contamination
8/9/2019 Gmp Partii
26/76
26
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
12.24
Premises: production areas
Minimie ris( o" crosscontamination
$edicated and self#contained facilities for some products such ashighly sensitizing materials %e&g& penicillins' or biologicalpreparations %e&g& live microorganisms'
Separate facilities for other products such as some antibiotics,hormones, cytoto"ic substances
(on#pharmaceuticals normally not in the same facility, e&g&pesticides, herbicides
8/9/2019 Gmp Partii
27/76
27
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
12.32, 12.26, 12.31
Premises: production areas
8aout in accordance with se0uence o" )roduction
A))ro)riate c!ean!iness !e#e!
Ade0uate wor( and in)rocess stora%e s)ace
9rder! and !o%ica! )ositionin% o" e0ui)ment minimizes ris of contamination, mi"#ups and missing
production steps
S)ecia!! desi%ned areas "or )ac(a%in%
8aout to a#oid mi:u)s and crosscontamination
8/9/2019 Gmp Partii
28/76
2$
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
12.27
Premises: production areas
Startin% and )ac(a%in% materia!s, intermediates and u!(e:)osed to en#ironment Interior surfaces %walls, floors, ceilings' ) smooth, free from
cracs and open *oints (o shedding of particles !asy and effective cleaning permitted
Disin"ection i" needed
8/9/2019 Gmp Partii
29/76
2
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
12.2$, 12.2
Premises: production areas
Desi%n o" )i)ewor(, !i%ht "ittin%s, and #enti!ation )oints / norecesses that are di""icu!t to c!ean
Access "or maintenance "rom outside )roduction areas
Drains o" ade0uate sie, and e0ui))ed to )re#ent ac("!ow
9)en channe!s a#oided
8/9/2019 Gmp Partii
30/76
3
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
12.3
Premises: production areas
""ecti#e #enti!ation with aircontro! "aci!ities
;nc!udin% "i!tration o" air to asu""icient !e#e! to )re#entcontamination and crosscontamination / a!so e:terna!
en#ironment -ontro! o" tem)erature and
re!ati#e humidit wherenecessar
8/9/2019 Gmp Partii
31/76
31
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
16.10 - 11
+$oiding cross contamination
S)ecia! )recautions shou!d e ta(en to )re#ent %eneration anddissemination o" dust
Pro)er air contro! / su))! and e:traction, suita!e 0ua!it
Due to uncontro!!ed re!ease o" dust gas particles (apours sprays organisms residue
insects
Dedicated and se!"contained areas "or =i(e (accines =i(e ;acterial preparations !ertain other ;iological materials
Penicillin products 16.12(a)
8/9/2019 Gmp Partii
32/76
32
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
16.12(b)
+$oiding cross contamination cont!d"
-am)ai%n )roduction Separation in time
+ollowed by appropriate cleaning
alidated cleaning procedure
&enti!ation sstems and air!oc(s -ppropriately designed ventilation system with air supply and
e"traction systems
Supply or incoming air should be filtered
.ecirculation of air versus /001 fresh air supply
Proper airflow patterns
Pressure differentials -ppropriately designed airlocs
16.12 (c and d)
8/9/2019 Gmp Partii
33/76
33
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
16.12(e)
+$oiding cross contamination cont!d"
-!othin%
Protection of operator and product
+it for its intended use
Highly potent products or those of particular ris # need for
special protective clothing
Personnel should not move between areas producing different
products
2arments need to be cleaned
8/9/2019 Gmp Partii
34/76
34
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
16.12(f, h and i)
+$oiding cross contamination cont!d"
-!eanin% and decontamination Procedure for removing soil and dirt
.emove all cleaning chemical residues or disinfectant residues
.emove and3or reduce micro#organisms
alidated %nown effectiveness of the procedure'
Use cleanliness status labels 4est for residues
-!osed )rocessin% sstems
+or e"ample5 totally enclosed water purification systems
4ans fitted with appropriate filtration # without removable lids
Present special cleaning difficulties, sometimes useclean#in#place %CIP' 16.12(g)
8/9/2019 Gmp Partii
35/76
35
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
Sanitation in production operations
'or("!ow designed to avoid potential contamination
Access
to production areas restricted to authorized personnel
direct operators, 6C staff, warehouse staff, maintenance
personnel, cleaners the more critical the area # fewer number of persons there
Simu!taneous o)erations
not permissible to process different products in different areaswith a common ventilation system
permissible to carry out secondary pacaging activities for
different products within a pacing hall with ade7uate physicalseparation
8/9/2019 Gmp Partii
36/76
36
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
Sanitation in production operationscont!d"
Area c!earance chec(s Process o" chec(in%
all materials and documentation from the previous batchremoved
all plant and e7uipment thoroughly cleaned and appropriatestatus labelling
checlist useful =he area c!earance chec( shou!d e carried out two )ersons
between batches of same product, acceptable for both checsto be carried out by production personnel
for product changeover, second chec carried out by 6C staff
all checs carried out in accordance with written S8P andresults recorded on the batch documentation&
8/9/2019 Gmp Partii
37/76
37
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
-g- line clearance in pac.aging
';sence of all materials
from pre(ious run including
printing masters
8ncludes checks on
materials and components .atch num;er
E6piry date
Printed packaging material
including cartons leaflets
foil 0 0 0
8/9/2019 Gmp Partii
38/76
3$
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
Sanitation in production operationscont!d"
-!eanin% and c!eanin% #a!idation degree of cleaning depends on whether consecutive batches are
of same or different product
-hec( c!eanin% a%ent is "u!! remo#ed
;" )ossi!e hot water a!one used "or c!eanin% all cleaning and disinfecting solutions carefully prepared and
e"piry dated
*or steri!e )roducts *ina! rinse with )uri"ied water, or water "or
in>ection
*u!! records (e)t
8/9/2019 Gmp Partii
39/76
3
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
Sanitation in production operationscont!d"
Maintenance and re)air
activities inevitable in manufacturing area
Should present no ris to product
'hene#er )ossi!e, a!! )!anned maintenance outside norma!
o)eratin% hours
mer%enc wor( in wor(in% area "o!!owed thorou%h c!ean
down and disin"ection e"ore manu"acturin% recommences
Area c!earance -
8/9/2019 Gmp Partii
40/76
4
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
/asic Principles on premises in GMP
=he tem)erature and
re!ati#e humidit shou!d e
contro!!ed, monitored in
accordance with an S9P,
and the resu!ts recorded.
=he !imits shou!d e
a))ro)riate accordin% to
the materia!s stored and
)roduct )rocessed
8/9/2019 Gmp Partii
41/76
41
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
12.6
Premises: maintenance
-are"u! maintenance done
8/9/2019 Gmp Partii
42/76
42
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
12.33, 12.34
Premises of 0ualit( 1ontrol 2a&s
- !aoratories shou!d e se)arate "rom )roduction areas
Se)arate areas "or io!o%ica!, microio!o%ica! and radioisoto)emethods
Suita!e desi%n with su""icient s)ace to a#oid mi:u)s andcrosscontamination
Suita!e s)ace "or stora%e sam)!es, re"erence standards,so!#ents, rea%ents and records
8/9/2019 Gmp Partii
43/76
8/9/2019 Gmp Partii
44/76
44
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
Part : Documentation
O;Iecti(es
1. =o re#iew %enera! re0uirements "or documents
2. =o re#iew s)eci"ic re0uirements "or each document
3. =o consider current issues a))!ica!e to our countries
8/9/2019 Gmp Partii
45/76
45
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
15.1
Documentation
ssentia! )art o" the A sstem, "or a!! as)ects o" MP Pur)ose o" documentation
$efines specifications and procedures for all materials andmethods of manufacture and control
!nsures all personnel now what to do and when to do it !nsure that authorized persons have all information necessary for
release of product !nsures documented evidence, traceability, provide records and
audit trail for investigation !nsures availability of data for validation, review and statistical
analysis
Desi%n and use
$epends upon manufacturer Some documents combined into one, sometimes separate
8/9/2019 Gmp Partii
46/76
46
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
Documentation
D t ti
8/9/2019 Gmp Partii
47/76
47
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
'h are documents so im)ortant?
-ommunication
-ost Audit trai!
Documentation
8/9/2019 Gmp Partii
48/76
4$
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
15.2
Documentation: general principles
Documents shou!d e
$esigned, prepared, reviewed, distributed with care
-pproved by appropriate responsible persons
-om)! with mar(etin% authoriation
Desi%n o" documentation im)ortant
8oo( at the St!e o" the document
Instructions in the imperative
Short sentences preferred to long sentences
D l l !d"
8/9/2019 Gmp Partii
49/76
4
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
15.4
Documentation: general principles cont!d"
!ontents of documents should ;e clear @easy to understandA and
include e0g0
4itle, nature, ob*ective or purpose
=ayout in orderly fashion
Easy to ;e filled in and checked !lear and reada;le including copies made
2o errors if master documents are copied for ,orking documents
D i l i i l !d"
8/9/2019 Gmp Partii
50/76
5
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
15.5
Documentation: general principles cont!d"
Documentation contro!
Regular re(ie, of documents
Fept up to date @currentA ) amended
+uperseded documents remo(ed and not used
$istribution and retrieval of documentation
Retention time for superseded documents
D t t i d t
8/9/2019 Gmp Partii
51/76
51
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
15.6 15.8
Data entr( in documents:
!lear reada;le and indeli;le
Jesign to allo, for sufficient space for entries
!hanges to entries: signed, dated and reason given
original entry still readable Entries at the time of action
'll significant actions recorded tracea;le
D t t i d t
8/9/2019 Gmp Partii
52/76
52
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
15.9
Data entr( in e4documents:
Electronic data processing systems photographic systems or other relia;lemeans:
+ystems require +OPs and records
'ccuracy of records checked
'uthori-ed persons ) access and changes
Pass,ord controlled
Entries checked .atch records stored electronically:
Protected 9ac#up transfer, e&g& magnetic tape, microfilm, paper print#outs
Records kept 1 year after e6piry date of product
Jata readily a(aila;le during retention period
Diff t t f d t
8/9/2019 Gmp Partii
53/76
53
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
Different t(pes of documents
=a;els
+pecifications and testing procedures
Master formulae and instructions
.atch processing and ;atch packaging records
+tandard Operating Procedures @+OPsA
Records
Stoc control and distribution records
=og ;ooks
Other documents K
2a&els
8/9/2019 Gmp Partii
54/76
54
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
15.10
2a&els
What must ;e la;elledL Containers, e7uipment, premises
=a;el informationL Clear, unambiguous, company
format Intermediates and bul products
!olours can ;e used e0g0 green@acceptedA red @reIectedA
Jifferent types of la;els e0g0cleaning status production stagestatus of materials
Other types of la;elsL
Specifications
8/9/2019 Gmp Partii
55/76
55
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
15.14 - 15.17
Specifications
'uthori-ed appro(ed signed and dated Starting, pacaging materials and finished products5 include tests
on identity, content, purity, 7uality Intermediates and bul :ater, solvents and reagents
/! /' or documentation centre
Periodic re(ie,
!ompliance ,ith current pharmacopoeia
Pharmacopoeia reference standards and spectra a(aila;le
Specifications: Starting and pac.aging
8/9/2019 Gmp Partii
56/76
56
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
15.18 -15.19
Specifications: Starting and pac.agingmaterials
8nclude:
2ame @e0g0 822A and internal code
Pharmacopoeia @if applica;leA
/ualitati(e and quantitati(e requirements and limits
Other data may include:
+upplier
+ampling procedure or reference
+torage conditions precautions
Retest date
Specifications: 5inis%ed products
8/9/2019 Gmp Partii
57/76
57
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
15.21
Specifications: 5inis%ed products
8nclude:
2ame and code reference
2ames of acti(es @e0g0 822A
Gormula
Josage form package details
Reference to sampling
/ualitati(e and quantitati(e requirements and limits
+torage conditions and precautions
+helf life
Production documentation
8/9/2019 Gmp Partii
58/76
5$
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
15.22 15.30
Production documentation
Bu!( manu"acturin%
Master formulae
9atch Processing .ecords
Pac(a%in%
Pacaging instructions
9atch Pacaging .ecords
The Maste f!"#$ae and the %ac&aging inst#cti!ns ae the c!nnecti!nd!c#"ent bet'een Ma&eting #th!iati!n, *+ecificati!ns and the
act#a$ ec!ds
Documentation
8/9/2019 Gmp Partii
59/76
5
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
Documentation
8/9/2019 Gmp Partii
60/76
6
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
Standard Operating procedures SOPs"
8/9/2019 Gmp Partii
61/76
61
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
Standard Operating procedures SOPs"
Jescri;e one particular process in detail
Required for a lot of acti(ities mentioned in WHO chapter 1
Many other acti(ities outlined else,here in *MPs also require
+OPs
+OPs are non);atch related
'uthori-ation
Periodic re(ie,
ersion management
!lear instruction no am;iguities 15.31 15.48
Standard Operating procedures SOPs"
8/9/2019 Gmp Partii
62/76
62
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
Part 3: 0ualification and Validation
8/9/2019 Gmp Partii
63/76
63
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
0
De"initions
a$idati!n
'ction of pro(ing in accordance ,ith the principles of *MP that any
procedure process equipment material acti(ity or system actually
leads to the e6pected results
#a$ificati!n
'ction of pro(ing that any premises systems and items of equipment
,ork correctly and actually lead to the e6pected results
@alidation usually incorporates the concept of qualificationA$!ssa/
S(stem life c(cle:
8/9/2019 Gmp Partii
64/76
64
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
( (
8/9/2019 Gmp Partii
65/76
65
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
Desi%n ua!i"ication DE: documentary e(idence that apremises equipment or process has ;een desi%nedinaccordance ,ith *MP requirements
;nsta!!ation ua!i"ication ;E: documentary e(idence that apremises equipment or process has ;een ui!t and insta!!edinaccordance ,ith *MP requirements
9)erationa! ua!i"ication 9E: documentary e(idence that apremises equipment or process o)eratein accordance ,ith*MP requirements
Per"ormance ua!i"ication PE: documentary e(idence that a
specific process ,ill consistently produce a product meeting itspre)determined specifications and quality attri;utes 4.3
0ualification and Validation
8/9/2019 Gmp Partii
66/76
66
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
Principle
ua!i"ication and #a!idation shou!d e done in accordance with an
on%oin% )ro%ramme
Initial 7ualification and validation
-nnual review
Maintain continued #a!idation status
Po!ic descried in re!e#ant documentation, e.%. 0ua!it manua!, or
&a!idation Master P!an4.5, 4.6
6(pes of $alidation documentation
8/9/2019 Gmp Partii
67/76
67
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
alidation Master Plan @MPA: policy responsi;ilities management of
(alidation process etc0
alidation protocols
alidation reports
+tandard Operating Procedures @+OPsA
Validation Master Plan VMP"
8/9/2019 Gmp Partii
68/76
6$
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
'ppro(al page and ta;le of contents
8ntroduction and o;Iecti(es
Gacility and process description
Personnel planning and scheduling
Responsi;ilities of (alidation team mem;ers
Process control aspects Equipment apparatus processes and systems qualified (alidated
and to ;e qualified or (alidated
'cceptance criteria
Jocumentation e0g0(alidation protocols and reports
+OPs
Training requirements and other elementsK
)e*uirements to Validation documentation
8/9/2019 Gmp Partii
69/76
6
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
!learly defines responsi;ility of performing (alidation !onducted in accordance ,ith predefined appro(ed (alidation
protocols !onducted in accordance ,ith predefined appro(ed acceptance
criteria Recorded results and conclusions presented in ,ritten (alidation
reports prepared and stored Processes and procedures should ;e esta;lished on the ;asis of
these results Premises utilities equipment and processes !ritical importance and particular attention paid to (alidation of:
-nalytical test methods
-utomated systems Cleaning procedures 4.7 4.11
0ualification and Validation
8/9/2019 Gmp Partii
70/76
7
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
nne 6
WHO References
ood manu"acturin% )ractices MPE %uide!ines on the
#a!idation o" manu"acturin% )rocesses
&a!idation o" ana!tica! )rocedures used in the e:amination o")harmaceutica! materia!s
7ample of priorities for process $alidation
8/9/2019 Gmp Partii
71/76
71
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
=)e o" )rocess
8/9/2019 Gmp Partii
72/76
72
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
A 0ua!i"ication or #a!idation )rotoco! ma contain
8b*ectives of the validation and 7ualification study
Site of the study .esponsible personnel $escription of the e7uipment
S8Ps
Standards Criteria for the relevant products and processes
0ualification and Validation
8/9/2019 Gmp Partii
73/76
73
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
A 0ua!i"ication or #a!idation re)ort shou!d re"!ect the e!ements
o" the )rotoco!, and ma contain e!ements such as:
4itle
8b*ective of the study
.eference to the protocol
$etails of materials, e7uipment, instruments, personnel
Programmes and cycles used
$etails of procedure and test methods
etc&
Possi&le pro&lems in 0ualification and
8/9/2019 Gmp Partii
74/76
74
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
pValidation
=ack of time
=ack of personnel
=ack of e6perience and kno,ledge
!hanges to the process
Prospecti(e (ersus retrospecti(e (alidation
=ack of documentation infrastructure
=ack of implementation of (alidation
Poorly designed documents
Some GMP topics not co$ered toda(:
8/9/2019 Gmp Partii
75/76
75
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines
&endor e#a!uation
Personne!
=rainin%
8/9/2019 Gmp Partii
76/76
76
Prequalification Programme: Access to Antimalarial, Antituberculosis andanti HIV/AIDS Drugs and HIV/AIDS Diagnostics of Acceptable QualityPrequalification Programme: Priority ssential !edicines